Original text
Rate this translation
Your feedback will be used to help improve Google Translate
Home
Medipharm Labs Corp.
MMJ Group Holdings Ltd (MMJJF) MediPharm Labs (MLCPF) Extraction Agreement with TerrAscend
Published Jan 8 2019
4 min read

MMJ Group Holdings Ltd (MMJJF) MediPharm Labs (MLCPF) Extraction Agreement with TerrAscend

MMJ Group Holdings Ltd (MMJJF) MediPharm Labs (MLCPF) Extraction Agreement with TerrAscend
Perth, Australia (ABN Newswire) - MMJ Group Holdings Limited (ASX:MMJ) (OTCMKTS:MMJJF) ("MMJ") is pleased to attach a copy of a news release by MediPharm Labs Inc ("MediPharm Labs") (CVE:LABS) (OTCMKTS:MLCPF) announcing that it has entered into a multi-year cannabis extraction agreement with TerrAscend Corp. (CNSX:TER) (OTCMKTS:TRSSF) ("TerrAscend").

MMJ owns approximately 4.4 million shares for a 4.5% shareholding (at a cost of CAD$0.85 per share) and 2.9 million warrants (exercisable at CAD$1.20 per share by October 2020) in MediPharm Labs.

To view the news release, please visit:
http://abnnewswire.net/lnk/8R6HHUPS



About MMJ Group Holdings Ltd:

MMJ Group Holdings Ltd (ASX:MMJ) is a global cannabis investment company. MMJ owns a portfolio of minority investments and aims to invest across the full range of emerging cannabis-related sectors including healthcare, technology, infrastructure, logistics, processing, cultivation, equipment and retail. For MMJ's latest investor presentation and news, please visit: http://www.mmjphytotech.com.au/investors/



Source:

MMJ Group Holdings Ltd



Contact:

Investor and Media Enquiries:
Jason Conroy
Chief Executive Officer
T: +61-2-8098-0819
E: info@mmjgh.com.au